| __timestamp | Lantheus Holdings, Inc. | Viking Therapeutics, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 13673000 | 22223073 |
| Thursday, January 1, 2015 | 14358000 | 6966842 |
| Friday, January 1, 2016 | 12203000 | 9000499 |
| Sunday, January 1, 2017 | 18125000 | 13741186 |
| Monday, January 1, 2018 | 17071000 | 19040000 |
| Tuesday, January 1, 2019 | 20018000 | 23559000 |
| Wednesday, January 1, 2020 | 32788000 | 31931000 |
| Friday, January 1, 2021 | 44966000 | 44981000 |
| Saturday, January 1, 2022 | 311681000 | 54234000 |
| Sunday, January 1, 2023 | 77707000 | 63806000 |
Unleashing the power of data
In the ever-evolving landscape of biotechnology, research and development (R&D) investments are pivotal. Over the past decade, Lantheus Holdings, Inc. and Viking Therapeutics, Inc. have demonstrated contrasting strategies in their R&D expenditures. From 2014 to 2023, Lantheus Holdings saw a staggering 470% increase in R&D spending, peaking in 2022 with a remarkable 311 million dollars. This surge underscores their commitment to innovation and market leadership. Meanwhile, Viking Therapeutics, with a more consistent growth trajectory, increased their R&D investments by approximately 187% over the same period, reaching 64 million dollars in 2023. This steady rise reflects their strategic focus on sustainable development. As these companies continue to invest in groundbreaking research, their financial strategies offer valuable insights into the future of biotech innovation.
Research and Development Expenses Breakdown: Vertex Pharmaceuticals Incorporated vs Viking Therapeutics, Inc.
Research and Development: Comparing Key Metrics for Alnylam Pharmaceuticals, Inc. and Lantheus Holdings, Inc.
Analyzing R&D Budgets: Halozyme Therapeutics, Inc. vs Lantheus Holdings, Inc.
Lantheus Holdings, Inc. or Corcept Therapeutics Incorporated: Who Invests More in Innovation?
Who Prioritizes Innovation? R&D Spending Compared for Lantheus Holdings, Inc. and PTC Therapeutics, Inc.
Research and Development: Comparing Key Metrics for Lantheus Holdings, Inc. and Catalyst Pharmaceuticals, Inc.
R&D Spending Showdown: Lantheus Holdings, Inc. vs MiMedx Group, Inc.
Viking Therapeutics, Inc. vs Amicus Therapeutics, Inc.: Strategic Focus on R&D Spending
R&D Spending Showdown: Viking Therapeutics, Inc. vs Bausch Health Companies Inc.
Research and Development Investment: Viking Therapeutics, Inc. vs Travere Therapeutics, Inc.
Research and Development: Comparing Key Metrics for Viking Therapeutics, Inc. and Novavax, Inc.
Viking Therapeutics, Inc. or Evotec SE: Who Invests More in Innovation?